Sana Biotechnology SANA ... delivering an average negative surprise of 26.03%. Only $1 to See All Zacks' Buys and Sells We're not kidding. Several years ago, we shocked our members by offering ...
Hosted on MSN28d
SANA Gears Up to Report Q4 Earnings: What's in the Cards?Factors to Consider Regarding SANA’s Q4 Earnings In the absence of a marketed product, investors are advised to look forward to the company’s pipeline updates in the upcoming earnings call ...
Sana Biotechnology SANA, a clinical-stage company, is expected to report its fourth-quarter results soon. The company leverages its proprietary hypoimmune technology to develop cell engineering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback